Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating nab-paclitaxel with cisplatin and sintilimab as neoadjuvant therapy for locally advanced cervical cancer; the study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nab-paclitaxel (paclitaxel protein-bound)
• Sintilimab (sintilimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Cervical Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING